Induced interstitial pneumonitis: Role of pegylated interferon alpha 2b;Forme pegylée de l'interféron alpha 2b et pneumopathies interstitielles diffuses

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 4, 2002, Pages 405-408

  Rocca, Pierre ^a   Dumortier, Jérôme ^a   Tanière, Philippe ^a   Duperret, Serge ^a   Vial, Thierry ^a   Cottin, Vincent ^b   Delafosse, Bertrand ^a   Scoazec, Jean Yves ^a   Boillot, Olivier ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA2B INTERFERON; CEFTRIAXONE; LYSINE ACETYLSALICYLATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTRAL INSULIN; OFLOXACIN; OMEPRAZOLE; PEGINTERFERON ALPHA2B; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE 3 SULFOBENZOATE; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; TACROLIMUS; TARDYFERON; TOBRAMYCIN SULFATE; VANCOMYCIN;

ADULT; ARTICLE; BRONCHIOLITIS; CASE REPORT; HEPATITIS C VIRUS; HUMAN; INTERSTITIAL PNEUMONIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG TOXICITY; MALE;

ADULT; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS;

EID: 0036105513     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C
2. Interferon alfa-induced interstitial pneumonitis in a patient with cutaneous T-cell lymphoma
3. Alpha-interferon induced severe pneumonitis
4. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C
5. A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis
6. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis
7. A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration
8. Interstitial pneumonitis and interferon-alfa
9. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia
10. Pneumonie interstitielle á la suite d'un traitement par interféron-alpha
11. Interferon-related bronchiolitis obliterans organizing pneumonia
12. Drug-induced pulmonary disease. An update
13. BOOP in Europe
14. Ribavirin-current status of a broad spectrum antiviral agent
15. The toxicologic and pharmacologic properties of amantadine hydrochloride
16. Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective
17. Prophylaxis and treatment of influenza virus infection
18. Hepatitis C: A multifaceted disease
19. BOOP (bronchiolitis obliterans organizing pneumonia) after renal transplantation
20. Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil
21. Pulmonary fibrosis secondary to administration of mycophenolate mofetil
22. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus
23. A case of bronchiolitis obliterans organizing pneumonia with renal dysfunction after renal transplantation
24. Pegylated interferon-alpha2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
25. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C
26. Renal filtration, absorption and catabolism of human alpha interferon
27. Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications
28. A pharmacokinetic model for alpha interferon administered subcutaneously